Polidori D - Search Results

1

Validation of a diet-induced Macaca fascicularis model of non-alcoholic steatohepatitis with dietary and pioglitazone interventions.

Camacho RC, Polidori D, Chen T, Chen B, Hsu HH, Gao B, Marella M, Lubomirski M, Beavers T, Cabrera J, Wong P, Nawrocki AR. Camacho RC, et al. Among authors: polidori d. Diabetes Obes Metab. 2023 Apr;25(4):1068-1079. doi: 10.1111/dom.14955. Epub 2023 Jan 17. Diabetes Obes Metab. 2023. PMID: 36546607

2

Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.

Sha S, Polidori D, Heise T, Natarajan J, Farrell K, Wang SS, Sica D, Rothenberg P, Plum-Mörschel L. Sha S, et al. Among authors: polidori d. Diabetes Obes Metab. 2014 Nov;16(11):1087-95. doi: 10.1111/dom.12322. Epub 2014 Jul 8. Diabetes Obes Metab. 2014. PMID: 24939043 Clinical Trial.

3

Apparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy.

Polidori D, Capuano G, Qiu R. Polidori D, et al. Diabetes Obes Metab. 2016 Apr;18(4):348-54. doi: 10.1111/dom.12615. Epub 2016 Jan 25. Diabetes Obes Metab. 2016. PMID: 26661906 Free PMC article. Clinical Trial.

4

A long-acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model.

Zheng S, Polidori D, Wang Y, Geist B, Lin-Schmidt X, Furman JL, Nelson S, Nawrocki AR, Hinke SA. Zheng S, et al. Among authors: polidori d. Clin Transl Sci. 2023 Aug;16(8):1431-1444. doi: 10.1111/cts.13543. Epub 2023 May 23. Clin Transl Sci. 2023. PMID: 37154518 Free PMC article.

5

Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects.

Sha S, Devineni D, Ghosh A, Polidori D, Chien S, Wexler D, Shalayda K, Demarest K, Rothenberg P. Sha S, et al. Among authors: polidori d. Diabetes Obes Metab. 2011 Jul;13(7):669-72. doi: 10.1111/j.1463-1326.2011.01406.x. Diabetes Obes Metab. 2011. PMID: 21457428 Clinical Trial.

6

Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double-blind, crossover study.

Sha S, Polidori D, Farrell K, Ghosh A, Natarajan J, Vaccaro N, Pinheiro J, Rothenberg P, Plum-Mörschel L. Sha S, et al. Among authors: polidori d. Diabetes Obes Metab. 2015 Feb;17(2):188-97. doi: 10.1111/dom.12418. Epub 2015 Jan 5. Diabetes Obes Metab. 2015. PMID: 25421015 Free PMC article. Clinical Trial.

7

Effect of canagliflozin on liver function tests in patients with type 2 diabetes.

Leiter LA, Forst T, Polidori D, Balis DA, Xie J, Sha S. Leiter LA, et al. Among authors: polidori d. Diabetes Metab. 2016 Feb;42(1):25-32. doi: 10.1016/j.diabet.2015.10.003. Epub 2015 Nov 11. Diabetes Metab. 2016. PMID: 26575250 Clinical Trial.

8

Dissection of hepatic versus extra-hepatic insulin clearance: Ethnic differences in childhood.

Piccinini F, Polidori DC, Gower BA, Fernandez JR, Bergman RN. Piccinini F, et al. Diabetes Obes Metab. 2018 Dec;20(12):2869-2875. doi: 10.1111/dom.13471. Epub 2018 Aug 20. Diabetes Obes Metab. 2018. PMID: 30019375 Free PMC article.

9

Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.

Cusi K, Bril F, Barb D, Polidori D, Sha S, Ghosh A, Farrell K, Sunny NE, Kalavalapalli S, Pettus J, Ciaraldi TP, Mudaliar S, Henry RR. Cusi K, et al. Among authors: polidori d. Diabetes Obes Metab. 2019 Apr;21(4):812-821. doi: 10.1111/dom.13584. Epub 2018 Dec 18. Diabetes Obes Metab. 2019. PMID: 30447037 Clinical Trial.

10

Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: A cross-sectional and longitudinal study from the Yale Pediatric NAFLD cohort.

Tricò D, Galderisi A, Mari A, Polidori D, Galuppo B, Pierpont B, Samuels S, Santoro N, Caprio S. Tricò D, et al. Among authors: polidori d. Diabetes Obes Metab. 2020 Sep;22(9):1628-1638. doi: 10.1111/dom.14076. Epub 2020 May 31. Diabetes Obes Metab. 2020. PMID: 32363679 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters